The additive interactions between ondansetron and droperidol for preventing postoperative nausea and vomiting

Anesthesia and Analgesia

Volumn 103, Issue 5, 2006, Pages 1155-1162

  Chan, Matthew T V ^a   Choi, Kai C ^a   Gin, Tony ^a   Chui, Po Tong ^a   Short, Timothy G ^b   Yuen, Pong Mo ^a   Poon, Amy H Y ^a   Apfel, Christian C ^c   Gan, Tong J ^d  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATRACURIUM; DEXTROPROPOXYPHENE PLUS PARACETAMOL; DOLOGESIC; DROPERIDOL; FENTANYL; MORPHINE; ONDANSETRON; PROCHLORPERAZINE; PROPOFOL; UNCLASSIFIED DRUG;

ADULT; ANESTHESIA INDUCTION; ARTICLE; CALCULATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG POTENTIATION; DRUG RESPONSE; ELECTROCARDIOGRAPHY; FEMALE; GYNECOLOGIC SURGERY; HEART RATE; HUMAN; LAPAROSCOPIC SURGERY; MAJOR CLINICAL STUDY; META ANALYSIS; NAUSEA AND VOMITING; PAIN ASSESSMENT; PATIENT MONITORING; POSTOPERATIVE CARE; PRIORITY JOURNAL; PROPHYLAXIS; QT PROLONGATION; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SEDATION; SIDE EFFECT; SYSTEMATIC REVIEW; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADOLESCENT; ADULT; DROPERIDOL; DRUG INTERACTIONS; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MIDDLE AGED; ONDANSETRON; POSTOPERATIVE NAUSEA AND VOMITING;

EID: 33750337027     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/01.ane.0000239223.74552.0a     Document Type: Article

References (22)

1. Gan TJ, Meyer T, Apfel CC, et al. Consensus guidelines for managing postoperative nausea and vomiting. Anesth Analg 2003;97:62-71.
2. Tramer MR, Reynolds DJ, Moore RA, McQuay HJ. Efficacy, dose-response, and safety of ondansetron in prevention of postoperative nausea and vomiting: a quantitative systematic review of randomized placebo-controlled trials. Anesthesiology 1997;87:1277-89.
3. Eberhart LH, Morin AM, Bothner U, Georgieff M. Droperidol and 5-HT3-receptor antagonists, alone or in combination, for prophylaxis of postoperative nausea and vomiting. A meta-analysis of randomised controlled trials. Acta Anaesthesiol Scand 2000;44:1252-7.
4. Apfel CC, Korttila K, Abdalla M, et al. A factorial trial of six interventions for the prevention of postoperative nausea and vomiting. N Engl J Med 2004;350:2441-51.
5. Bazett HC. An analysis of the time-relation of electrocardiograms. Heart 1920;7:353-67.
6. Pueyo FJ, Carrascosa F, Lopez L, et al. Combination of ondansetron and droperidol in the prophylaxis of postoperative nausea and vomiting. Anesth Analg 1996;83:117-22.
7. Klockgether-Radke A, Neumann S, Neumann P, et al. Ondansetron, droperidol and their combination for the prevention of post-operative vomiting in children. Eur J Anaesthesiol 1997;14:362-7.
8. Bugedo G, Gonzalez J, Asenjo C, et al. Ondansetron and droperidol in the prevention of postoperative nausea and vomiting. Br J Anaesth 1999;83:813-4.
9. Wu O, Belo SE, Koutsoukos G. Additive anti-emetic efficacy of prophylactic ondansetron with droperidol in out-patient gynecological laparoscopy. Can J Anaesth 2000;47:529-36.
10. Shende D, Bharti N, Kathirvel S, Madan R. Combination of droperidol and ondansetron reduces PONV after pediatric strabismus surgery more than single drug therapy. Acta Anaesthesiol Scand 2001;45:756-60.
11. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7:177-88.
12. Jaccard J. Interaction effects in logistic regression. Thousand Oaks, CA: Sage Publications, 2001.
13. Apfel CC, Korttila K, Abdalla M, et al. An international multicenter protocol to assess the single and combined benefits of antiemetic interventions in a controlled clinical trial of a 2X2X2X2X2X2 factorial design (IMPACT). Control Clin Trials 2003;24:736-51.
14. Jonker DM, Visser SA, van der Graaf PH, et al. Towards a mechanism-based analysis of pharmacodynamic drug-drug interactions in vivo. Pharmacol Ther 2005;106:1-18.
15. Tramèr MR, Reynolds DJM, Moore RA, McQuay HJ. Efficacy, dose-response, and safety of ondansetron in prevention of postoperative nausea and vomiting: a qualitative systematic review of randomized placebo-controlled trials. Anesthesiology 1997;87:1277-89.
16. Eberhart LH, Morin AM, Bothner U, Georgieff M. Droperidol and 5-HT3-receptor antagonists, alone or in combination, for prophylaxis of postoperative nausea and vomiting. A meta-analysis of randomised controlled trials. Acta Anaesthesiol Scand 2000;44:1252-7.
17. Habib AS, El-Moalem HE, Gan TJ. The efficacy of the 5-HT3 receptor antagonists combined with droperidol for PONV prophylaxis is similar to their combination with dexamethasone. A meta-analysis of randomized controlled trials. Can J Anaesth 2004;51:311-19.
18. Tang J, Wang B, White PF, et al. The effect of timing of ondansetron administration on its efficacy, cost-effectiveness, and cost-benefit as a prophylactic antiemetic in the ambulatory setting. Anesth Analg 1998;86:274-82.
19. White PF. Droperidol: a cost-effective antiemetic for over thirty years [Editorial]. Anesth Analg 2002;95:789-90.
20. Shafer SL. Safety of patients reason for FDA black box warning on droperidol. Anesth Analg 2004;98:551-2.
21. White PF, Song D, Abrao J, et al. Effect of low-dose droperidol on the QT interval during and after general anesthesia: a placebocontrolled study. Anesthesiology 2005;102:1101-5.
22. Charbit B, Albaladejo P, Funck-Brentano C, et al. Prolongation of QTc interval after postoperative nausea and vomiting treatment by droperidol or ondansetron. Anesthesiology 2005;102:1094-100.